Center for projects to support the office of generic drugs under the generic drug user fee amendments ?closely associated
Ended Awarded Last action
- Contract number
- HHSF22313004
- Awardee
-
Mckinsey & Company, Inc. Washington D.c. UEI N6JZARL64EW5
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $719,438
Award facts
- Contract value 49% obligated
-
- $719,437.73 Current, with exercised options
- $1,482,922.66 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Washington, DC 20036, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$44,047 | |
| Original award | $763,485 |
Quick answers
Who was awarded contract HHSF22313004?
HHSF22313004 was awarded to Mckinsey & Company, Inc. Washington D.c. by Food and Drug Administration (Department of Health and Human Services) on August 10, 2013.
How much is contract HHSF22313004 worth?
The government has obligated $719,438 on HHSF22313004. Its potential value, with all options, is $1,482,923.
Is contract HHSF22313004 an order under another contract?
Yes. HHSF22313004 is a BPA call under GS10F0118S-HHSF223201010014B, a blanket purchase agreement, on The Professional Services Schedule (PSS).
Was contract HHSF22313004 competed?
The extent of competition for HHSF22313004 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award